Kyle Munz

Our top 5 most-read spinal muscular atrophy (SMA) articles of 2024 featured coverage that broadened clinical understandings of SMA as a multisystem disorder, the benefits and newborn screening programs, and novel biomarker discoveries that have continued to progress SMA research. […]

Am J Manag Care. 2024;30(Spec. No. 13):SP1041-SP1043 _____ On September 26, 2024, speakers gathered in Park City, Utah, to discuss the state of kidney care and how risk stratification, public policy, and interdisciplinary communication can enhance patient outcomes. Hosted in

Our top coverage from this year’s Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) included new insights into markers of disease progression in multiple sclerosis (MS), the emerging role of artificial intelligence (AI), advancements in imaging, the promise

This year’s 2024 American Society of Hematology (ASH) Annual Meeting & Exposition featured novel research in the long-term safety and efficacy of ruxolitinib (Jakafi) for patients with polycythemia vera (PV) as well as those experiencing chronic graft-vs-host disease (cGVHD). Two

Sleep equity among children belonging to minoritized groups deserves more clinical attention, according to a new report published today in JAMA Network Open. This cross-sectional study found that racially and ethnically diverse pediatric populations continue exhibiting worse sleep outcomes compared

Oussama Wazni, MD, section head of Cardiac Electrophysiology and Pacing, Cleveland Clinic, participated in this year’s centennial American Heart Association (AHA) conference, held in Chicago, Illinois, from November 16-18. His presentation shared novel insights from the OPTION trial, which evaluated

Following a structured exercise regimen that combines both aerobic and resistance activity can help patients with obstructive sleep apnea (OSA) better manage their condition. New findings published in the Journal of Clinical Medicine not only indicate the benefits of physical

The latest CDC data on sexually transmitted infections (STIs) offers, as Jonathan Mermin, MD, MPH, director of the CDC National Center for HIV, Viral Hepatitis, STD, and TB Prevention, believes, “a glimmer of hope” that modern endeavors to combat the

For patients with restless legs syndrome (RLS), superficial heat-cold application could pave the way towards better sleep quality. This approach additionally represents a cost-effective, medication-free method for many patients, according to findings published in Nursing Open.1 Restless legs syndrome remains

Earlier this year, the dual therapy of ponatinib (Iclusig; Takeda) plus chemotherapy received an accelerated FDA approval as a primary treatment for patients with newly-diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). With the advent of this medication, updates to